(Q48704096)

14 February 2018

title

Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels. (English)

1 reference

14 February 2018

0 references

1 reference

P De Boer

1

1 reference

14 February 2018

P Enrico

2

1 reference

14 February 2018

J Wright

3

1 reference

14 February 2018

L D Wise

4

1 reference

14 February 2018

W Timmerman

5

1 reference

14 February 2018

E Moor

6

1 reference

14 February 2018

D Dijkstra

7

1 reference

14 February 2018

H V Wikström

8

1 reference

14 February 2018

B H Westerink

9

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

14 February 2018

published in

Brain Research

1 reference

14 February 2018

volume

758

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

83-91

1 reference

14 February 2018

Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Molecular diversity of the dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Characterization of the human dopamine D3 receptor expressed in transfected cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

A functional test identifies dopamine agonists selective for D3 versus D2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

[3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Do autoreceptors mediate dopamine agonist — induced yawning and suppression of exploration? A critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following ?-methyltyrosine or Reserpine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

Differential Effects of Dopamine Antagonists on Evoked Dopamine Release from Slices of Striatum and Nucleus Accumbens in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901438-2

10.1016/S0006-8993(96)01438-2

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018